Thymoquinone-Loaded Soy-Phospholipid-Based Phytosomes Exhibit Anticancer Potential against Human Lung Cancer Cells
- PMID: 32806507
- PMCID: PMC7463966
- DOI: 10.3390/pharmaceutics12080761
Thymoquinone-Loaded Soy-Phospholipid-Based Phytosomes Exhibit Anticancer Potential against Human Lung Cancer Cells
Retraction in
-
RETRACTED: Alhakamy et al. Thymoquinone-Loaded Soy-Phospholipid-Based Phytosomes Exhibit Anticancer Potential against Human Lung Cancer Cells. Pharmaceutics 2020, 12, 761.Pharmaceutics. 2024 Jan 23;16(2):156. doi: 10.3390/pharmaceutics16020156. Pharmaceutics. 2024. PMID: 38399350 Free PMC article.
Abstract
Thymoquinone (TQ), a natural polyphenol, has been associated with various pharmacological responses; however, low bioavailability of TQ limits its clinical application. Thus, a novel phytosomal delivery system of TQ-Phospholipon® 90H complex (TQ-phytosome) was developed by refluxing combined with anti-solvent precipitation. This TQ delivery system was optimized by a three-factor, three-level Box-Behnken design. The optimized TQ-phytosome size was (45.59 ± 1.82 nm) and the vesicle size was confirmed by transmission electron microscopy. The in vitro release pattern of the formulation indicated a biphasic release pattern, where an initial burst release was observed within 2 h, followed by a prolonged release. A remarkable increase in dose-dependent cytotoxicity was evident from the significant decrease in IC50 value of TQ-phytosomes (4.31 ± 2.21 µM) against the A549 cell line. The differential effect of TQ-phytosomes in cell cycle analysis was observed, where cancer cells were accumulated on G2-M and pre-G1 phases. Furthermore, increased apoptotic induction and cell necrosis of TQ-phytosomes were revealed with the annexin V staining technique via activation of caspase-3. In reactive oxygen species (ROS) analysis, TQ-phytosomes acted to significantly increase ROS generation in A549 cells. In conclusion, the sustained release profile with significantly-improved anticancer potential could be obtained with TQ by this phytosomal nanocarrier platform.
Keywords: Box-Behnken design; ROS generation; apoptotic potential; biphasic release; cell cycle arrest; cytotoxicity; thymoquinone.
Conflict of interest statement
The authors declare no conflict of interest. The funders had no role in the design of the study; in the collection, analyses, or interpretation of data; in the writing of the manuscript, or in the decision to publish the results.
Figures









Similar articles
-
Optimized Icariin Phytosomes Exhibit Enhanced Cytotoxicity and Apoptosis-Inducing Activities in Ovarian Cancer Cells.Pharmaceutics. 2020 Apr 11;12(4):346. doi: 10.3390/pharmaceutics12040346. Pharmaceutics. 2020. Retraction in: Pharmaceutics. 2024 Jan 30;16(2):194. doi: 10.3390/pharmaceutics16020194. PMID: 32290412 Free PMC article. Retracted.
-
Improving the Cytotoxic Activity of Hinokitiol from Drug-Loaded Phytosomal Formulation Against Breast Cancer Cell Lines.Int J Nanomedicine. 2024 Oct 12;19:10321-10339. doi: 10.2147/IJN.S476667. eCollection 2024. Int J Nanomedicine. 2024. PMID: 39415963 Free PMC article.
-
Optimization and Characterization of Cuscuta reflexa Extract Loaded Phytosomes by the Box-Behnken Design to Improve the Oral Bioavailability.J Oleo Sci. 2022 Apr 29;71(5):671-683. doi: 10.5650/jos.ess21318. Epub 2022 Apr 5. J Oleo Sci. 2022. PMID: 35387912
-
Thymoquinone (2-Isoprpyl-5-methyl-1, 4-benzoquinone) as a chemopreventive/anticancer agent: Chemistry and biological effects.Saudi Pharm J. 2019 Dec;27(8):1113-1126. doi: 10.1016/j.jsps.2019.09.008. Epub 2019 Sep 25. Saudi Pharm J. 2019. PMID: 31885471 Free PMC article. Review.
-
Recent Findings on Thymoquinone and Its Applications as a Nanocarrier for the Treatment of Cancer and Rheumatoid Arthritis.Pharmaceutics. 2021 May 22;13(6):775. doi: 10.3390/pharmaceutics13060775. Pharmaceutics. 2021. PMID: 34067322 Free PMC article. Review.
Cited by
-
Boosting curcumin activity against human prostatic cancer PC3 cells by utilizing scorpion venom conjugated phytosomes as promising functionalized nanovesicles.Drug Deliv. 2022 Dec;29(1):807-820. doi: 10.1080/10717544.2022.2048133. Drug Deliv. 2022. PMID: 35266425 Free PMC article.
-
Phytosome-Enhanced Secondary Metabolites for Improved Anticancer Efficacy: Mechanisms and Bioavailability Review.Drug Des Devel Ther. 2025 Jan 11;19:201-218. doi: 10.2147/DDDT.S483404. eCollection 2025. Drug Des Devel Ther. 2025. PMID: 39816849 Free PMC article. Review.
-
Advances in Parenteral Nanocarriers and Delivery Devices: A Comprehensive Review.Curr Pharm Des. 2025;31(23):1844-1865. doi: 10.2174/0113816128338217250114073640. Curr Pharm Des. 2025. PMID: 40143399 Review.
-
Carvacrol-Loaded Phytosomes for Enhanced Wound Healing: Molecular Docking, Formulation, DoE-Aided Optimization, and in vitro/in vivo Evaluation.Int J Nanomedicine. 2023 Oct 12;18:5749-5780. doi: 10.2147/IJN.S421617. eCollection 2023. Int J Nanomedicine. 2023. PMID: 37849641 Free PMC article.
-
Formulation, optimization, and nephrotoxicity evaluation of an antifungal in situ nasal gel loaded with voriconazole‒clove oil transferosomal nanoparticles.Drug Deliv. 2021 Dec;28(1):2229-2240. doi: 10.1080/10717544.2021.1992040. Drug Deliv. 2021. PMID: 34668818 Free PMC article.
References
-
- McMullen S., Hess L.M., Kim E.S., Levy B., Mohamed M., Waterhouse D., Wozniak A., Goring S., Müller K., Muehlenbein C., et al. Treatment Decisions for Advanced Non-Squamous Non-Small Cell Lung Cancer: Patient and Physician Perspectives on Maintenance Therapy. Patient. 2019;12:223–233. doi: 10.1007/s40271-018-0327-3. - DOI - PMC - PubMed
-
- Li Y., Fu J., Yuan X., Hu C. Simvastatin inhibits the proliferation of A549 lung cancer cells through oxidative stress and up-regulation of SOD2. Pharmazie. 2014;69:610–614. - PubMed
Publication types
Grants and funding
LinkOut - more resources
Full Text Sources
Research Materials